Sustained correction of associative learning deficits after brief, early treatment in a rat model of Fragile X Syndrome

Antonis Asiminas, Adam D. Jackson, Susana R. Louros, Sally M. Till, Teresa Spanò, Owen Dando, Mark F. Bear, Sumantra Chattarji, Giles E. Hardingham, Emily K. Osterweil,

Science Translational Medicine · 2019 · 87 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

KO rats with lovastatin between 5 and 9 weeks of age, during the normal developmental period that this associative memory capability is established, prevents the emergence of deficits but has no effect in wild-type animals. Moreover, we observe no regression of cognitive performance in the FXS rats over several months after treatment. This restoration of the normal developmental trajectory of cognitive function is associated with the sustained rescue of both synaptic plasticity and altered protein synthesis. The findings provide proof of concept that the impaired emergence of the cognitive repertoire in neurodevelopmental disorders may be prevented by brief, early pharmacological intervention.

References

40